Agios Pharm Stock Overlap Studies Triple Exponential Moving Average

AGIO Stock  USD 38.02  0.15  0.39%   
Agios Pharm overlap studies tool provides the execution environment for running the Triple Exponential Moving Average study and other technical functions against Agios Pharm. Agios Pharm value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of overlap studies indicators. As with most other technical indicators, the Triple Exponential Moving Average study function is designed to identify and follow existing trends. Agios Pharm overlay technical analysis usually involve calculating upper and lower limits of price movements based on various statistical techniques. Please specify Time Period to run this model.

The output start index for this execution was thirty-nine with a total number of output elements of twenty-two. Agios Pharm Triple Exponential Moving Average indicator shows smoothing effect of Agios Pharm price series composite of a single exponential moving average, a double exponential moving average and a triple exponential moving average.

Agios Pharm Technical Analysis Modules

Most technical analysis of Agios Pharm help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Agios from various momentum indicators to cycle indicators. When you analyze Agios charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Agios Pharm Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Agios Pharm. We use our internally-developed statistical techniques to arrive at the intrinsic value of Agios Pharm based on widely used predictive technical indicators. In general, we focus on analyzing Agios Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Agios Pharm's daily price indicators and compare them against related drivers, such as overlap studies and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Agios Pharm's intrinsic value. In addition to deriving basic predictive indicators for Agios Pharm, we also check how macroeconomic factors affect Agios Pharm price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2023 2024 (projected)
Days Sales Outstanding38.2436.11
PTB Ratio1.531.45
Hype
Prediction
LowEstimatedHigh
33.3137.7042.09
Details
Intrinsic
Valuation
LowRealHigh
31.0835.4739.86
Details
Naive
Forecast
LowNextHigh
27.3331.7236.11
Details
10 Analysts
Consensus
LowTargetHigh
35.4939.0043.29
Details

Become your own money manager

As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.

Did you try this?

Run Commodity Channel Now

   

Commodity Channel

Use Commodity Channel Index to analyze current equity momentum
All  Next Launch Module

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Warren Buffett Holdings Idea
Warren Buffett Holdings
Invested over 40 shares
Dividend Beast Idea
Dividend Beast
Invested over 50 shares
Driverless Cars Idea
Driverless Cars
Invested over 200 shares
Baby Boomer Prospects Idea
Baby Boomer Prospects
Invested over 40 shares
Blockchain Idea
Blockchain
Invested few shares
Impulse Idea
Impulse
Invested few shares
Macroaxis Index Idea
Macroaxis Index
Invested few shares
FinTech Idea
FinTech
Invested few shares
Electronic Equipment Idea
Electronic Equipment
Invested few shares
When determining whether Agios Pharm offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Agios Pharm's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Agios Pharm Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Agios Pharm Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Agios Pharm. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
To learn how to invest in Agios Stock, please use our How to Invest in Agios Pharm guide.
You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Agios Pharm. If investors know Agios will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Agios Pharm listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
10.26
Revenue Per Share
0.582
Quarterly Revenue Growth
0.212
Return On Assets
(0.18)
Return On Equity
0.5366
The market value of Agios Pharm is measured differently than its book value, which is the value of Agios that is recorded on the company's balance sheet. Investors also form their own opinion of Agios Pharm's value that differs from its market value or its book value, called intrinsic value, which is Agios Pharm's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Agios Pharm's market value can be influenced by many factors that don't directly affect Agios Pharm's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Agios Pharm's value and its price as these two are different measures arrived at by different means. Investors typically determine if Agios Pharm is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Agios Pharm's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.